PAVmed (PAVM) Net Equity Issued and Repurchased (2019 - 2025)
PAVmed (PAVM) posted quarterly Net Equity Issued and Repurchased of $1.6 million for Q4 2025, up 229.89% year-over-year from $499257.9 in Q4 2024, and up 95.84% quarter-over-quarter from $841000.0 in Q1 2025.
PAVmed (PAVM) Net Equity Issued and Repurchased (2019 - 2025) Analysis & Trends
PAVmed's Net Equity Issued and Repurchased history runs 7 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased rose 229.89% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $2.5 million (up 112.11% YoY), while the FY2025 annual figure was $2.5 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q4 2025 stood at $1.6 million, up from $841000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $54.9 million in Q4 2021, with the low at -$1.3 million in Q4 2024.
- The 5-year median for Net Equity Issued and Repurchased is $304000.0 (2021), against an average of $7.6 million.
- The sharpest annual moves came in 2023 and 2024: Net Equity Issued and Repurchased surged 4956.67% in 2023, then slumped 187.03% in 2024.
- PAVmed's Net Equity Issued and Repurchased stood at $54.9 million in 2021, then plunged by 100.05% to -$30000.0 in 2022, then soared by 4956.67% to $1.5 million in 2023, then plunged by 187.03% to -$1.3 million in 2024, then jumped by 229.89% to $1.6 million in 2025.
- Business Quant data shows PAVM's Net Equity Issued and Repurchased at $1.6 million in Q4 2025, $841000.0 in Q1 2025, and -$1.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | PAVmed | 32.48 Mn | 28.69 Mn | -89,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.65 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Mar 31, 2025 | 841,000.00 |
| Mar 31, 2025 | 841,000.00 |
| Dec 31, 2024 | -1.27 Mn |
| Dec 31, 2024 | -1.27 Mn |
| Jun 30, 2024 | 922,000.00 |
| Jun 30, 2024 | 922,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | 1.46 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Jun 30, 2023 | 984,000.00 |
| Jun 30, 2023 | 984,000.00 |
| Mar 31, 2023 | 182,000.00 |
| Mar 31, 2023 | 182,000.00 |
| Dec 31, 2022 | -30,000.00 |
| Dec 31, 2022 | -30,000.00 |